Top compounds associated with response to SPRY1


Feature Type Standardized
Nominal ANOVA
mRNA CIL70 CTRPv2 pan-cancer AAC 0.086 0.08
mRNA Cytarabine GDSC1000 pan-cancer AAC 0.066 0.08
mRNA Pazopanib FIMM pan-cancer AAC 0.32 0.08
mRNA lapatinib GDSC1000 pan-cancer AAC 0.09 0.08
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.064 0.08
mRNA LE-135 CTRPv2 pan-cancer AAC -0.067 0.08
mRNA BI-2536 FIMM pan-cancer AAC 0.22 0.08
mRNA myricetin CTRPv2 pan-cancer AAC -0.069 0.08
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC 0.062 0.08
mRNA phenformin GDSC1000 pan-cancer AAC 0.057 0.08
Download CSV